Shares of Proteome Sciences plc (LON:PRM) hit a new 52-week high during mid-day trading on Friday . The company traded as high as GBX 4.10 ($0.05) and last traded at GBX 3.87 ($0.05), with a volume of 769000 shares changing hands. The stock had previously closed at GBX 3.62 ($0.05).
Separately, FinnCap reiterated a “corporate” rating and set a GBX 7 ($0.09) price target on shares of Proteome Sciences in a research report on Tuesday, April 24th.
In other Proteome Sciences news, insider Martin Diggle purchased 500,000 shares of the company’s stock in a transaction dated Monday, August 13th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £20,000 ($25,513.46).
Proteome Sciences Company Profile (LON:PRM)
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes.
Further Reading: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.